Full document - International Hospital Federation

Innovation and clinical specialities: oncology
References continued
lumpectomy, and lumpectomy plus radiation for the management of invasive breast cancer.
New England Journal of Medicine ;347, 1233-1241. 2002.
79.
Veronesi U CNMLeal. Twenty-year followup of a randomized study comparing breast
conserving surgery with radical mastectomy for early breast cancer. New England Journal of
Medicine 347, 1227-1232. 2002. Ref Type: Generic
80.
Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy and surgery in early
breast cancer. New England Journal of Medicine 333, 1444-1445. 1995.
81.
Tachi M, Yamada A, Tachi M, Yamada A. Choice of flaps for breast reconstruction. [Review] [57
refs]. International Journal of Clinical Oncology 2005 Oct;10(5):289-97.
82.
Taylor CW, Horgan K, Dodwell D, Taylor CW, Horgan K, Dodwell D. Oncological aspects of breast
reconstruction. [Review] [84 refs]. Breast 2005 Apr;14(2):118-30.
83.
Chagpar AB, Chagpar AB. Skin-sparing and nipple-sparing mastectomy: preoperative,
intraoperative, and postoperative considerations. [Review] [75 refs]. American Surgeon 2004
May;70(5):425-32. Abstract Only
84.
Chagpar AB, Chagpar AB. Advances in the management of localized breast cancer: an
overview.[see comment]. [Review] [25 refs]. Journal of the Kentucky Medical Association 2004
May;102(5):202-8. Abstract Only
85.
Rainsbury RM, Rainsbury RM. Skin-sparing mastectomy. [Review] [48 refs]. British Journal of
Surgery 2006 Mar;93(3):276-81.
86.
Pickren HW RJAHJ. Modification of conventional mastectomy: a detailed study of lymph node
involvement and follow-up information to show its practicality. Cancer 18, 942. 1965.
87..
Luini A, Gatti G, Ballardini B, Zurrida S, Galimberti V, Veronesi P, et al. Development of axillary
surgery in breast cancer. [Review] [43 refs]. Annals of Oncology 2005 Feb;16(2):259-62.
88.
Leidenius MH, Leidenius MHK. Sentinel node biopsy in breast cancer. [Review] [123 refs]. Acta
Radiologica 2005 Dec;46(8):791-801.
89.
Mark C.Kelley MDaNHMDbKMMMDPhDc*. Lymphatic mapping and sentinel lymphadenectomy
for breast cancer. The American Journal of Surgery 188, 49-61. 2004.
90.
Schulze T, Bembenek A, Schlag PM, Schulze T, Bembenek A, Schlag PM. Sentinel lymph node
biopsy progress in surgical treatment of cancer. [Review] [217 refs]. Langenbecks Archives of
Surgery 2004 Nov;389(6):532-50.
91.
Morrow M SEBLea. Standard for breast conservation therapy in the management of invasive
breast carcinoma. CA Cancer J Clin 52, 277-300. 2002.
92.
Yarnold J, Yarnold J. Latest developments in local treatment: radiotherapy for early breast
cancer. [Review] [28 refs]. Annals of Oncology 2005;16 Suppl 2:ii170-ii173.
93.
Orecchia R, Veronesi U, Orecchia R, Veronesi U. Intraoperative electrons. [Review] [30 refs].
Seminars in Radiation Oncology 2005 Apr;15(2):76-83.
94.
Orecchia R, Luini A, Veronesi P, Ciocca M, Franzetti S, Gatti G, et al. Electron intraoperative
treatment in patients with early-stage breast cancer: data update. [Review] [46 refs]. Expert
Review of Anticancer Therapy 2006 Apr;6(4):605-11.
95.
Arthur DW, Morris MM, Vicini FA, Arthur DW, Morris MM, Vicini FA. Breast cancer: new radiation
treatment options. [Review] [26 refs]. Oncology (Huntington) 1636 Nov;18(13):1621-9.
96.
Vicini FA, Arthur DW, Vicini FA, Arthur DW. Breast brachytherapy: North American experience.
[Review] [28 refs]. Seminars in Radiation Oncology 2005 Apr;15(2):108-15.
97.
Keisch ME, Keisch ME. Accelerated partial breast irradiation: the case for current use. [Review]
[31 refs]. Breast Cancer Research 2005;7(3):106-9.
98.
Smith I, Chua S, Smith I, Chua S. Medical treatment of early breast cancer. I: adjuvant
treatment. [Review] [0 refs]. BMJ 2006 Jan 7;332(7532):34-7.
99.
KD Miller GS. Chemotherapy for early and advanced breast cancer . Cancer of the Breast 5th
edition, 659-687 Elsevier Science St Louis . 2007. Elsevier Science St Louis .
100.
Smith I, Chua S, Smith I, Chua S. Medical treatment of early breast cancer. III: chemotherapy.
[Review] [0 refs]. BMJ 2006 Jan 21;332(7534):161-2.
101.
Cariati M, nett-Britton TM, Pinder SE, Purushotham AD, Cariati M, nett-Britton TM, et al.
"Inflammatory" breast cancer. [Review] [81 refs]. Surgical Oncology 2005 Nov;14(3):133-43.
102.
Cristofanilli M, Buzdar AU, Hortobagyi GN, Cristofanilli M, Buzdar AU, Hortobagyi GN. Update on
the management of inflammatory breast cancer. [Review] [61 refs]. Oncologist 2003;8(2):141-8.
103.
Giordano SH, Hortobagyi GN, Giordano SH, Hortobagyi GN. Inflammatory breast cancer: clinical
progress and the main problems that must be addressed. [Review] [31 refs]. Breast Cancer
Research 2003;5(6):284-8.
104.
Apffelstaedt JP, Apffelstaedt JP. Locally advanced breast cancer in developing countries: the
place of surgery. [Review] [69 refs]. World Journal of Surgery 2003 Aug;27(8):917-20.
105.
Shenkier T, Weir L, Levine M, Olivotto I, Whelan T, Reyno L, et al. Clinical practice guidelines for
the care and treatment of breast cancer: 15. Treatment for women with stage III or locally
advanced breast cancer.[see comment]. [Review] [73 refs]. CMAJ Canadian Medical
Association Journal 2004 Mar 16;170(6):983-94.
106.
Giordano SH, Giordano SH. Update on locally advanced breast cancer. [Review] [105 refs].
Oncologist 2003;8(6):521-30.
107.
Giordano SH, Hortobagyi GN, Giordano SH, Hortobagyi GN. Inflammatory breast cancer: clinical
progress and the main problems that must be addressed. [Review] [31 refs]. Breast Cancer
Research 2003;5(6):284-8.
108.
Goble S, Bear HD, Goble S, Bear HD. Emerging role of taxanes in adjuvant and neoadjuvant
therapy for breast cancer: the potential and the questions. [Review] [90 refs]. Surgical Clinics
of North America 2003 Aug;83(4):943-71.
109.
World Health Organization G. Symptom relief in terminal illness. 1998. Ref Type: Generic
110.
Leonard RC, Untch M, Von KF, Leonard RC, Untch M, Von Koch F. Management of anaemia in
patients with breast cancer: role of epoetin. [Review] [73 refs]. Annals of Oncology 2005
May;16(5):817-24.
111.
Barrett-Lee P, Bokemeyer C, Gascon P, Nortier JW, Schneider M, Schrijvers D, et al.
Management of cancer-related anemia in patients with breast or gynecologic cancer: new
insights based on results from the European Cancer Anemia Survey. Oncologist 2005
Oct;10(9):743-57.
112.
Schwartzberg LS, Yee LK, Senecal FM, Charu V, Tomita D, Wallace J, et al. A randomized
comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of
chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer. Oncologist
2004;9(6):696-707.
113.
Kligman L, Wong RK, Johnston M, Laetsch NS, Kligman L, Wong RKS, et al. The treatment of
lymphedema related to breast cancer: a systematic review and evidence summary. [Review]
[30 refs]. Supportive Care in Cancer 2004 Jun;12(6):421-31.
114.
Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA, et al. Breast cancerrelated
lymphedema. [Review] [60 refs]. Mayo Clinic Proceedings 2005 Nov;80(11):1480-4.
115.
Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS, Weil RJ, et al. Breast cancer metastasis
to the central nervous system. [Review] [69 refs]. American Journal of Pathology 2005
Oct;167(4):913-20.
116.
Knobf MT, Knobf MT. The influence of endocrine effects of adjuvant therapy on quality of life
outcomes in younger breast cancer survivors. [Review] [101 refs]. Oncologist 2006
Feb;11(2):96-110.
117.
Edwards AG, Hailey S, Maxwell M, Edwards AGK, Hailey S, Maxwell M. Psychological
interventions for women with metastatic breast cancer.[see comment]. [Review] [71 refs].
Cochrane Database of Systematic Reviews 2004;(2):CD004253.
118.
Maguire P, Maguire P. ABC of breast diseases. Psychological aspects. [Review] [0 refs]. BMJ
1994 Dec 17;309(6969):1649-52.
119.
Mosher CE, noff-Burg S, Mosher CE, noff-Burg S. A review of age differences in psychological
adjustment to breast cancer. [Review] [56 refs]. Journal of Psychosocial Oncology 2005;23(2-
3):101-14.
120.
Walker LG, Eremin O, Walker LG, Eremin O. Psychological assessment and intervention: future
prospects for women with breast cancer. [Review] [45 refs]. Seminars in Surgical Oncology
1996 Jan;12(1):76-83.
121.
Bloom HJG RWHE. Natural history of untreated breast cancer (1805-1933): Comparison of
untreated and treated cases according to histological grade of malignancy. 5299, 213. 1962.
British Medical Journal.
122.
Lisa A.Carey et al. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer
Study. JAMA 295, 2492-2502. 6-7-2006.
123.
Mbonde MP, Amir H, Schwartz-Albiez R, Akslen LA, Kitinya JN, Mbonde MP, et al. Expression of
estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncology
Reports 2000 Mar;7(2):277-83.
124.
Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, et al. Routine assessment
of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets
in Kenyan women with breast cancer. Analytical & Quantitative Cytology & Histology 2006
Apr;28(2):97-103.
125.
Ikpatt OF, Ndoma-Egba R, Ikpatt OF, Ndoma-Egba R. Oestrogen and progesterone receptors in
Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Central
African Journal of Medicine 2003 Nov;49(11-12):122-6.
126.
Cary Gross. New Research Suggests Access, Genetic Differences Play Role in High Minority
Cancer Death Rate. Journal of the National Cancer Institute 98:10, 669. 2006.
127.
James J.Dignam. The Ongoing Search for the Sources of the Breast Cancer Survival Disparity.
Journal of Clincal Oncology 24:9, 1326-1329 James J. Dignam. 2006.
128.
Azadeh T.Stark et al. Race Modifies the Association between Breast Carcinoma Pathologic
Prognostic Indicators and the Positive Status for HER-2/neu. Cancer 104 / 10, 2189-2196. 2005.
129.
Houssami N, Cuzick J, Dixon JM, Houssami N, Cuzick J, Dixon JM. The prevention, detection,
and management of breast cancer. [Review] [39 refs]. Medical Journal of Australia 2006 Mar
6;184(5):230-4.
130.
R.S.Prichard ADKHBDEWMaNJO. The prevention of breast cancer. British Journal of Surgery ; :
90, 772-783. 2003.
131.
Kotsopoulos J, Narod SA, Kotsopoulos J, Narod SA. Towards a dietary prevention of hereditary
breast cancer. [Review] [240 refs]. Cancer Causes & Control 2005 Mar;16(2):125-38.
132.
Barthelmes L, Davidson LA, Gaffney C, Gateley CA, Barthelmes L, Davidson LA, et al.
Pregnancy and breast cancer. [Review] [11 refs]. BMJ 2005 Jun 11;330(7504):1375-8.
133.
Fentiman IS, Fourquet A, Hortobagyi GN, Fentiman IS, Fourquet A, Hortobagyi GN. Male breast
cancer. [Review] [142 refs]. Lancet 2006 Feb 18;367(9510):595-604.
134.
Giordano SH, Giordano SH. A review of the diagnosis and management of male breast cancer.
[Review] [95 refs]. Oncologist 2005 Aug;10(7):471-9.
135.
Krause W, Krause W. Male breast cancer-an andrological disease: risk factors and diagnosis.
[Review] [101 refs]. Andrologia 2004 Dec;36(6):346-54.
136.
von SK, von Smitten K. Surgical management of breast cancer in the future. [Review] [27
refs]. Acta Oncologica 2000;39(3):437-9.
137.
Buchholz TA, Strom EA, Perkins GH, McNeese MD, Buchholz TA, Strom EA, et al. Controversies
regarding the use of radiation after mastectomy in breast cancer. [Review] [24 refs].
Oncologist 2002;7(6):539-46.
138.
Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast Cancer in Limited-
Resource Countries: Health Care Systems and Public Policy. The Breast Journal
2006;12(s1):S54-S69.
108 Hospital and Healthcare Innovation Book 2009/2010